Wiebe C et al. |
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28729289
|
Tolkachjov SN et al. |
Frontal fibrosing alopecia among men: AÂ clinicopathologic study of 7 cases. |
2017 |
J. Am. Acad. Dermatol. |
pmid:28716436
|
Montenovo MI et al. |
Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients. |
2017 |
Exp Clin Transplant |
pmid:27309029
|
Das B et al. |
Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients. |
2017 |
Pediatr Transplant |
pmid:27862703
|
Wu Z et al. |
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients. |
2017 |
Eur. J. Clin. Pharmacol. |
pmid:27747372
|
Tamashiro EY et al. |
Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. |
2017 |
Drug Metab Pers Ther |
pmid:28593920
|
Fai D et al. |
Duration of response in vitiligo lesions after narrowband UVB phototherapy combined with tacrolimus ointment. |
2017 |
G Ital Dermatol Venereol |
pmid:28621124
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Ramirez R et al. |
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. |
2017 |
Am J Case Rep |
pmid:28465499
|
Harada S et al. |
Complete remission of angiolymphoid hyperplasia with eosinophilia using topical tacrolimus. |
2017 |
Eur J Dermatol |
pmid:28007668
|
Wan T et al. |
Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities. |
2017 |
Int J Nanomedicine |
pmid:28260894
|
Cui W et al. |
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. |
2017 |
Braz. J. Med. Biol. Res. |
pmid:28355356
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Vanhove T et al. |
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28168728
|
Qin HZ et al. |
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients. |
2017 |
BMC Nephrol |
pmid:28056860
|
Kim YK et al. |
New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients. |
2017 |
Drug Des Devel Ther |
pmid:29033547
|
Dutta D et al. |
Recruitment of calcineurin to the TCR positively regulates T cell activation. |
2017 |
Nat. Immunol. |
pmid:27941787
|
Terakura S et al. |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil. |
2017 |
Bone Marrow Transplant. |
pmid:27941766
|
Naicker D et al. |
Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28660366
|
Kannegieter NM et al. |
Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation. |
2017 |
Ther Drug Monit |
pmid:28640063
|